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Abstract: Background: To inform global health policies and resources planning, this paper analyzes
evolving trends in physical rehabilitation needs, using data on Years Lived with Disability (YLDs)
from the Global Burden of Disease Study (GBD) 2017. Methods: Secondary analysis of how YLDs
from conditions likely benefiting from physical rehabilitation have evolved from 1990 to 2017, for the
world and across countries of varying income levels. Linear regression analyses were used. Results:
A 66.2% growth was found in estimated YLD Counts germane to physical rehabilitation: a significant
and linear growth of more than 5.1 million YLDs per year (99% CI: 4.8–5.4; r2 = 0.99). Low-income
countries more than doubled (111.5% growth) their YLD Counts likely benefiting from physical
rehabilitation since 1990. YLD Rates per 100,000 people and the percentage of YLDs likley benefiting
from physical rehabilitation also grew significantly over time, across locations (all p < 0.05). Finally,
only in high-income countries did Age-standardized YLD Rates significantly decrease (p < 0.01;
r2 = 0.86). Conclusions: Physical rehabilitation needs have been growing significantly in absolute,
per-capita and in percentage of total YLDs. This growth was found globally and across countries of
varying income level. In absolute terms, growths were higher in lower income countries, wherein
rehabilitation is under-resourced, thereby highlighting important unmet needs.
Keywords: rehabilitation; global health; disability; global burden of disease; health services needs
and demand
1. Introduction
Worldwide rehabilitation needs are growing in tandem with global population growth, population
aging, and higher survival rates for people with severe health conditions and disability [1–3]. However,
to our knowledge, there is no up-to-date, systematic analysis quantifying worldwide epidemiological
trends for the whole set of health conditions likely benefiting from physical rehabilitation. In this
paper, we analyze how the global needs for physical rehabilitation have evolved from 1990 to 2017,
using data from the Global Burden of Disease Study (GBD) 2017.
The GBD study, which has incorporated data since 1990, is the most comprehensive global
epidemiological study to date. It combines data from the best available sources (e.g., scientific
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literature, official statistics from ministries of health, household surveys, vital registries, hospital data,
claims data [4,5]), processed with increasingly sophisticated modelling approaches (e.g., a continuously
updated Bayesian meta-regression tool) to provide rigorous global, regional, and national estimates
of relevant population health. The data sources used to ground the estimates are colossal and have
increased for each cycle of the GBD study. Most recently, the GBD 2017 used a total of 15,449 scientific
literature sources (6.5% and 47,4% more than the GBD 2106 and GBD 2015 cycles, respectively), 21,100
sources of epidemiological surveillance data (12.3% and 49.9% more than GDB 2016 and GBD 2015,
respectively), and data from an additional 148,842,107 hospital admissions globally, bringing the total
number of admissions that inform GBD estimation to more than 2.6 billion [5,6].
For the first time in the study’s history, the GBD 2017 reports data on injuries in terms of their
nature or consequence (e.g., hip fracture or spinal cord injury), in addition to and apart from their cause
(e.g., falls, road injuries, interpersonal violence) [6]. This new type of data is particularly germane to
the planning of services and resources in physical rehabilitation.
Others have used GBD study data to examine rehabilitation needs [7,8]. In the more recent
example, the World Health Organization (WHO) used data from the GBD 2015 to examine worldwide
needs for mental and physical rehabilitation. They found a 17.6% increase from 2005 to 2015
in Years Lived Disability (YLDs) for health conditions associated with severe disability, and that
a remarkable 75% of the total world’s YLDs in 2015 came from health conditions germane to
rehabilitation [7]. However, the WHO study did not examine physical rehabilitation needs distinct
from the rehabilitation of mental health conditions. Moreover, health conditions with mild disability
weights were not considered.
In addition to the WHO’s analysis, a number of studies have used GBD data to examine particular
conditions likely benefiting from physical rehabilitation, such as injuries (i.e., their causes) [9],
musculoskeletal conditions [10,11], neurological disorders [12,13], stroke [14], cardiovascular
diseases [15], chronic respiratory diseases [16], cancer [17], or HIV [18]. However, to our knowledge,
no study has used current GBD data to examine YLDs and potential needs for rehabilitation for the
broad spectrum of conditions potentially benefiting from physical rehabilitation.
Using publicly available data from the GBD 2017, this paper aimed to provide a systematic global
analysis of YLDs for the combined set of health conditions likely benefiting from physical rehabilitation,
and specifically answer the following study questions:
• How large are the estimated world’s YLDs (i.e., YLD counts, YLDs rates per 100,000 peole, and
age-standardized YLD rates) likely benefiting from physical rehabilitation in 2017?
• What is the percentage of the world’s YLDs likely benefiting from physical rehabilitation relative
to total YLDs?
• Did any of these estimates change significantly over time (i.e., since 1990)? If so, by how much?
and, finally,
• Did any of those trends differ across countries of varying income levels?
The answer to these questions would provide valuable benchmarks to inform global and
local health and rehabilitation policies, research, and advocacy. Moreover, such findings could
provide direction to funding priorities, as well as timely information for health system planning
and strengthening activities, including for determining needs for physical rehabilitation services, as a
means to allocate resources accordingly.
2. Methods
2.1. Study Design
Systematic, secondary analysis of public-domain data from the GBD 2017, extracted from the
freely-available web platform: the Global Health Data Exchange tool (http://ghdx.healthdata.org/
gbd-results-tool).
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2.2. Data Selection
From the list of YLD “causes” (i.e., underlying health conditions), “impairments”
(i.e., consequences of injury or diseases that have more than one diagnostic cause) and “injuries”
(i.e., the nature of the injury), the authors selected those deemed likely to benefit from physical
rehabilitation, as described below. Given that YLDs from “causes” are collective exhaustive, to avoid
double counting, we do not cumulatively select YLDs from Injuries as a “cause”, but only YLDs from
the nature of the injury. In addition, YLDs from “impairments” were limited to those not coming from
“causes” we had already selected.
We found no global standard to inform which health conditions potentially benefit from
physical rehabilitation; thus, in determining which conditions to focus on as potentially benefitting
from physical rehabilitation, we relied on the following: previous works using GBD data for
rehabilitation [7,8,19]; papers analyzing publication trends in physical rehabilitation and physical
therapy across conditions [20–22]; and finally on the below working definition [23–28].
Physical rehabilitation uses health-based approaches to optimize physical function and
participation in persons with physical impairments (e.g., mobility) or symptoms (e.g., low back
pain) that are amenable to recovery, prevention, or management from physical rehabilitation services,
facilities or providers (e.g., physical or occupational therapists). From this definition, we excluded
rehabilitation of people with oral, mental health, substance abuse disorders, intellectual or sensory
impairments per se, although partial overlap often occurs across different forms of rehabilitative
interventions for those conditions. Table 1 provides the full list of the included conditions.
Table 1. List of GBD causes, injuries and impairments selected as generating YLDs that might
potentially benefit from physical rehabilitation.
Causes
Communicable, Maternal, Neonatal or Nutritional:
• HIV/AIDs
• Leprosy; Zika




• Cardiovascular Diseases (includes Stroke)
• Chronic Respiratory Diseases
• Neurological disorders, except Epilepsy and Migraine (tension-type headaches included)
• Autism Spectrum Disorder
• Musculoskeletal conditions (includes Low back Pain and Neck Pain)
• Congenital Birth Defects, except Urogenital and Digestive
Injuries (nature of the)
• Amputations
• Burns
• Fractures, except skull
• Head Injuries
• Spinal Injuries
• Minor Injuries: muscle and tendon injuries, including sprains and strains lesser dislocations; Open wound(s)
• Dislocation of hip; Dislocation of knee; and Dislocation of shoulder
• Asphyxiation
• Crush injury; Nerve Injury; Severe Chest Injury
• Multiple fractures, dislocations, crashes, wounds, pains, and strains
Impairments (from the non-selected “causes” combined)
• Heart Failure
• Guillain-Barré Syndrome
Of note, within the application of the working definition and exclusion criteria, ‘dubious’ selection
decisions existed, e.g., health conditions for which it was not certain whether physical rehabilitation
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would be applicable or likely to provide benefits. For example, in Autism Spectrum Disorder,
psychosocial disfunction and rehabilitative approaches are often dominant, but sensory-processing
and motor impairments are prevalent and might benefit from physical rehabilitation as well [29–35].
In this context, we included this condition, although this choice may lead to an over-estimation of
physical rehabilitation needs. By contrast, we excluded some other health conditions, e.g., those for
which the benefit of rehabilitation has not been fully established yet. To reduce the bias towards over-
vs. under-estimation resulting from ‘dubious’ selection decisions, a priori evidence-based reasoning
was established for the conjunct of ‘dubious’ selection decisions (see Appendix A [29–79]).
Indeed, toward informing these decisions, we searched PubMed primarily for aggregated
evidence, preferably systematic reviews, on the effect of physical rehabilitation approaches
(e.g., physical therapy, cardiac rehabilitation, pulmonary rehabilitation) on each type of condition we
identified as potentially “dubious” for inclusion. We further gave priority to locating and selecting
systematic reviews from Cochrane Database of Systematic Reviews, whenever available (i.e., adding
“AND “Cochrane Database Syst Rev” [Journal]” to the search approach). As an example, we found that
the quantity, quality and strength of the evidence base for cardiac rehabilitation varies across various
cardiac conditions [36–42], but strong evidence that cardiac rehabilitation approaches are overall
cost-effective [44]. Thus, we included YLDs from all cardiovascular conditions as likely benefiting
from physical rehabilitation. As another example, we did not include any of the maternal, urological
or gynecological conditions, even though there is a body of literature pointing to the fact that physical
therapy can be useful for addressing incontinence and pelvic pain [70,71]. However, we found that
underlying evidence based on the use of physical therapy for the chronic pelvic pain and incontinence
is still considered insufficient [72,75], and the vast majority of urological and gynecological conditions
are not typically treated with physical rehabilitation. In addition, data weren’t available in the GBD
to identify particular urological/gynecological conditions potentially benefiting from rehabilitation,
i.e., there are no GBD “impairments” for consequences of urological/gynecological conditions such
as incontinence or pelvic pain. Thus, we excluded the maternal, urological or gynecological diseases
altogether, even though some might generate YLDs eventually benefiting from physical rehabilitation.
Finally, among the set of conditions in Table 1, we have selected a few (i.e., a subgroup) for a
separate analysis. This subgroup consisted of a narrow, highly conservative set of health conditions
historically associated with physical rehabilitation need, i.e., musculoskeletal and key neurological
diseases and injuries, including stroke, which frequently cause mobility impairments. Table 2 details
the exact subgroup of conditions selected for that separate analysis.
Table 2. Subgroup of health conditions for a separate, highly conservative analysis of physical
rehabilitation need.
Causes
Communicable, Maternal, Neonatal or Nutritional:
• Neonatal Disorders—only the Neonatal Encephalopathy due to Birth Asphyxia and Trauma
Non-communicable
• Stroke
• Neurological disorders, except Epilepsy, Dementia and Migraine
• Musculoskeletal conditions (includes Low back Pain and Neck Pain)
• Congenital Birth Defects—only Neuro Tube Defects + Congenital Musculoskeletal and Limb Anomalies
Injuries (nature of the)
• All of those in Table 1
2.3. Measures and Data Extraction:
Among the measures available in the webtool, we only extract data for YLDs, i.e., the aggregative
measure of the GBD study that focuses exclusively in non-fatal impacts of health conditions. YLDs are
the years lived with any short-term or long-term health loss weighted for severity by the disability
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weights. Concretely, YLDs are computed by combining the estimated prevalence of a health condition
with the estimated number of years people typically live with those sequelae, up to the population
life expectancy threshold. Importantly, the prevalence of sequelae from each condition is classified by
severity levels (e.g., mild, moderate, severe), each one having a respective disability weight [5,6,80,81].
For stroke, for example, disability weights vary from 0.019 for mild consequences to 0.588 for severe
consequences plus cognition problems, as determined by population preferences in large discrete
choice experiments [81]. Details on how YLDs and disability weights are determined, and the current
disability weights for all conditions, are provided elsewhere [5,6,81].
For our metrics, we extracted YLD data for prevalent number (YLD counts), rate (per 100,000
people), and percentage (percentage of YLDs from the selected conditions relative to the total amount of
YLDs). For age, we extracted YLDs both for all ages and age-standardized rates. With those specifications,
we obtained YLDs likely benefiting from physical rehabilitation under the following forms, used as
measures for the analysis:
• YLD Counts: Nominal amount of YLDs;
• YLD Rates: YLDs per 100,000 people, i.e., adjusted for population size only;
• Age-standardized YLD Rates: YLD values adjusted for both population size and ageing;
• Percentage of YLDs Benefiting from Physical Rehabilitation: The proportion of YLDs from
conditions likely benefiting from physical rehabilitation among total YLDs, provided in
percent values.
With regards to location, YLDs were extracted at the global level (i.e., for the world) and for high,
upper middle, lower middle, and low-income countries, according to the World Bank Income Levels. We
also extracted YLDs for all the years from 1990 to 2017, and for each selected health condition (Table 1).
Using the measures and specifications above, data extraction occurred in early December 2018.
All of the selected data were imported from the webtool to Excel spreadsheets for data storage,
management, and analysis.
2.4. Data Analysis
To determine the overall physical rehabilitation needs, we combined (i.e., summed) the YLDs data
for all the selected health conditions—within each of the “years”, “locations”, and “metrics”. Percent
changes from 1990 to 2017 were also computed for the combined values.
For inferential statistics, first we plotted the entire time series of the combined values for each
location, within each YLD metric. Using visualization and r2 values of pilot regression models, then we
determined which regression model type (i.e., linear, exponential, or logarithmic) best fit the plotted
data, and recorded the respective r2 values. Given differences in r2 values <0.02 between the models,
we retained the linear regression option. Linear regression analyses, using the analysis of variance
(ANOVA)—which account for the data on every year between 1990 and 2017, then were used to
test for statistical significance, notably of a non-zero yearly change, considering the full time-period
between 1990 and 2017, inclusively. We used the linear regression analytical approach even for the
data that fitted an exponential or logarithmic-type of regression. In those cases, we tested the models
using either the actual YLD values or a ‘log-transformed’ version of these. As there was no difference
in the statistical significance for any case, we retained linear regression analyses using the actual
YLD values. This facilitated the interpretation of the results since the coefficient and their confidence
intervals refer to the estimated annual change in YLD values, i.e., the slope of the linear regression line.
The significance level for the analysis was set at p = 0.05.
3. Results
Table 3 shows the YLDs for all conditions likely benefiting from rehabilitation. For instance, it
shows that, from 1990 to 2017, a 66.2% growth was found in estimated YLD Counts likely benefiting
from physical rehabilitation, with a significant and linear growth of more than 5.1 million YLDs per
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year (99% CI: 4.8–5.4; r2 0.99). While countries from all income levels had significant and linear growths,
low-income countries more than doubled (111.5% growth) their YLD Counts, likely benefiting from
physical rehabilitation for the 28-year period.
Table 3. Main analysis: YLDs from all conditions likely benefiting from Physical Rehabilitation
(1990–2017).






Coefficient 95% CI 99% CI
YLD Counts, Millions
World 206 343 66.2% Linear 0.99 5.10 * 4.88–5.32 4.80–5.40
High-Income 58 79 37.4% Linear 0.99 0.81 * 0.77–0.84 0.76–0.86
Upper Middle-Income 76 123 62.1% Linear 0.99 1.78 * 1.69–1.87 1.66–1.90
Lower Middle-Income 62 119 90.4% Linear 0.99 2.10 * 2.02–2.19 1.99-2.22
Low-Income 10 21 111.5% Linear 1 0.39 * 0.38–0.40 0.38–0.41
YLD Rates
World 3825 4488 17.3% Linear 0.96 25.7 * 23.7–27.7 23.0–28.4
High-Income 5748 6643 15.6% Linear 0.98 33.1 * 31.1–35.1 30.4–35.8
Upper Middle-Income 3594 4669 29.9% Linear 0.96 42.6 * 39.3–46.0 38.1–47.2
Lower Middle-Income 3233 3806 17.7% Linear 0.96 21.6 * 19.9–23.2 19.3–23.8
Low-Income 2977 3112 4.5% Logarithmic 0.50 2.5 ** 0.40–4.55 −0.33–5.28
Age-Standardized YLD Rates
World 4377 4334 −1.0% Logarithmic 0.22 −0.62 −2.13–0.89 −2.66–1.42
High-Income 5007 4872 −2.7% Logarithmic 0.86 −5.36 * −6.76–(−3.96) −7.26–(−3.47)
Upper Middle-Income 4106 4080 −0.6% Linear 0.04 1.34 −1.38–4.06 −2.33–5.02
Lower Middle-Income 4262 4314 1.2% Linear 0.46 2.33 * 1.26–3.40 0.89–3.78
Low-Income 4189 4276 2.1% Logarithmic 0.15 0.29 −3.29–3.87 −4.55–5.14
% of YLDs Benefiting from Physical Rehabilitation (among Total YLDs)
World 36.7% 40.2% 9.5% Linear 0.97 0.135 * 0.125–0.145 0.122–0.148
High-Income 47.6% 48.6% 2.2% Linear 0.87 0.030 * 0.026–0.035 0.024–0.037
Upper Middle-Income 37.9% 42.2% 11.4% Linear 0.97 0.170 * 0.157–0.183 0.153–0.187
Lower Middle-Income 30.7% 35.9% 16.8% Linear 0.98 0.200 * 0.189–0.211 0.185–0.215
Low-Income 27.8% 32.1% 15.4% Linear 0.97 0.155 * 0.145–0.165 0.141–0.169
Data obtained from: http://ghdx.healthdata.org/gbd-results-tool. Abbreviations: YLD—Year Lived with Disability.
Legend: * p < 0.01, ** p < 0.05. Notes: The “b coefficient” refers to the annual change within the linear regression
model. Different population structures apply to countries with varying income levels, so cross-location comparisons
are not valid for the metric YLD Counts.
Table 3 also shows significant growths in estimated YLD Rates for the same time-period,
worldwide and across countries of all income levels. However, for low-income countries, the growth
was not linear (i.e., best fit in a logarithmic model (r2 = 0.5)) and was only significant at a 95% confidence
level (p = 0.02). Of note, upper middle-income countries had a yearly growth of 42.6 YLDs per 100,000
people (99% CI: 38.1–47.2; r2 = 0.96), significantly higher than any of the comparators, i.e., no overlap
among the 99% CIs.
On Age-standardized YLD Rates, which adjusted YLDs for population size and ageing, Table 3
shows that only high-income and lower middle-income countries had a significant change since 1990,
but, while the latter had a linear growth (99% CI: 0.89–3.78; r2 = 0.46), the former had a logarithmic
decrease (r2 = 0.86; p < 0.01). Overall, in this metric, we observed the smallest magnitude of changes: a
maximum of 2.7% change from 1990 to 2017.
In a final metric, Table 3 shows that the Percentage of YLDs Benefiting from Physical Rehabilitation
significantly and linearly increased across locations (all: p < 0.01; minimum r2 = 0.87). However, while
high-income countries had the highest percent value in 2017 (48.6%), low and middle-income countries
(LMICs) grew significantly on an order of up to seven times: 0.200 (99% CIs 0.185–0.215) versus 0.030
(99 CIs 0.024–0.037). Figure 1 provides a graphical representation of the data on this metric, while
Supplementary Material for the three other YLD metrics.
Finally, Table 4 quantifies YLDs for a conservative subgroup of health conditions historically
associated with physical rehabilitation need, i.e., key musculoskeletal and neurological conditions
often resulting, primarily, in mobility impairments. The table reveals that a narrow set of conditions
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accounted for 225 million YLDs in 2017, nearly two-thirds (65.6%) of the total physical rehabilitation
needs (see Table 3). On the evolution over time, the subgroup shows a pattern of the results similar to
that of the whole set of conditions, with a few differences relative to the larger group as follows.
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Figure 1. Percentage of YLDs Benefiting from Physical Rehabilitation among Total YLDs for the globe
and across countries of varying income level. Linear regression lines (dotted) displayed.
Table 4. YLDs from a narrow set (i.e., subgroup) of health conditions benefiting from Physical
Rehabilitation (1990–2017).






Coefficient 95% CI 99% CI
YLD Counts, Millions
World 135 225 66.6% Linear 0.99 3.32 * 3.18–3.43 3.13–3.51
High-Income 40.3 54.7 35.6% Linear 0.99 0.52 * 0.50–0.55 0.49–0.56
Upper Middle-Income 49.7 82.8 66.5% Linear 0.99 1.24 * 1.19–1.29 1.17–1.31
Lower Middle-Income 38.8 73.9 90.6% Linear 0.99 1.30 * 1.24–1.36 1.22–1.38
Low-Income 5.9 12.5 113.6% Linear 0.98 0.24 * 0.23–0.25 0.22–0.26
YLD Rates
World 2506 2942 17.4% Linear 0.96 16.6 * 15.3–17.8 14.8–18.3
High-Income 4030 4597 14.1% Linear 0.97 19.7 * 18.3–21.1 17.8–21.6
Upper Middle-Income 2356 3143 33.4% Linear 0.98 30.8 * 28.9–32.6 28.3–33.2
Lower Middle-Income 2009 2367 17.8% Linear 0.98 13.2 * 12.0–14.4 11.6–14.9
Low-Income 1776 1875 5.6% Linear 0.68 3.08 * 2.22–3.94 1.92–4.24
Age-Standardized YLD Rates
World 2863 2812 −1.8% Logarithmic 0.61 −1.64 * −2.66–(−0.61) −3.02–(−0.25)
High-Income 3504 3397 −3.1% Logarithmic 0.83 −5.25 * −6.48–(−4.02) −6.92–(−3.59)
Upper Middle-Income 2664 2677 0.5% Linear 0.18 1.72 ** 0.23–3.22 −0.30–3.75
Lower Middle-Income 2657 2665 0.3% Linear 0.03 0.38 −0.44–1.20 −0.72–1.48
Low-Income 2564 2656 3.6% Linear 0.82 3.33 * 2.70–3.95 2.48–4.17
% of YLDs Benefiting from Physical Rehabilitation (among Total YLDs)
World 24.1% 26.4% 9.5% Linear 0.97 0.085 * 0.079–0.092 0.077–0.094
High-Income 33.3% 33.6% 0.9% Linear 0.12 0.005 −0.011–0.0005 −0.013–0.003
Upper Middle-Income 24.8% 28.4% 14.4% Linear 0.99 0.137 * 0.131–0.143 0.129–0.145
Lower Middle-Income 19.1% 22.3% 16.8% Linear 0.97 0.122 * 0.113–0.131 0.110–0.134
Low-Income 16.6% 19.4% 16.5% Linear 0.95 0.107 * 0.097–0.117 0.093–0.120
Data obtained from: http://ghdx.healthdata.org/gbd-results-tool. Abbreviations: YLD—Year Lived with Disability.
Legend: * p < 0.01, ** p < 0.05. Notes: The “b coefficient” refers to the annual change within the linear regression
model. Different population structures apply to countries with varying income levels, so cross-location comparisons
are not valid for the metric YLD Counts.
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First, YLD Rates for low-income countries grew over time in a linear shape, not logarithmic.
Second, the percentage of YLDs Benefiting from Physical Rehabilitation did not significantly change
for high-income countries for the subgroup of conditions, while it did in the main analysis. Lastly,
in the subgroup of conditions, Age-standardized YLD Rates decreased significantly worlwide but
increased significantly in low-income countries.
4. Discussion
This paper is, to our knowledge, the first systematic, secondary analysis of global physical
rehabilitation needs, based on publicly-available data from the most comprehensive source of global
epidemiological data to date, i.e., the GBD 2017. In addition to an over 66% global increase in YLD
Counts from 1990 to 2017 (5.1 million additional YLDs per year), we found a 17% increase in YLD Rates,
i.e., per size of the population. Therefore, the growth of YLDs from all conditions likely benefiting from
physical rehabilitation have outpaced that of the population. The key factor influencing per-capita
growth has been the global population ageing, which is why the world’s Age-Standardized YLD Rates
for all conditions potentially benefitting from physical rehabilitation did not significantly change over
the studied time-period. Aging of the population is likely to continue to be a worldwide phenomena
for the next several decades (e.g., global population with 65 years or more is predicted to double
by 2050, while the overall population is expected to grow by less than 30% [82]). Global needs for
physical rehabilitation are likely to continue to grow in tandem, with consequent increased demands
for physical rehabilitation.
Growth in need for physical rehabilitation was particularly prominent in LMICs. For instance,
in low-income countries, the YLD Counts more than doubled since 1990, likely due to population
growth from high fertility rates as YLD Rates grew at a much less pronounced rate. In fact, increases
in YLD Counts were inversely proportional to the countries’ income levels, such that the greatest
increase in needs for physical rehabilitation was found in countries with lower income levels and
the least rehabilitation infrastructure. Indeed, rehabilitation resources in many LMICs remain quite
limited [7,19,26,83,84]. The WHO estimates that skilled rehabilitation professionals for many LMICs
are currently about one-tenth of those required [7]. Hence, many argue that it is urgent to take action
to supply LMICs with increased resources, [24,26,83–87], and this is especially so given the higher
nominal increases of physical rehabilitation needs.
Nonetheless, we note that, in low-income countries, we also observed a logarithmic growth in YLD
Rates, flattening around the year 2000 (see Supplementary Material for the graphical representation of
the data, page 2). It is possible that global health activities for the Millennium Development Goals,
which focused, for example, in preventable neonatal and infectious conditions, have helped control
the rise in the prevalence of those conditions, and therefore the resulting YLDs in lower income
countries [88]. This interpretation is reinforced by the data in Table 4. In that analysis, which focused
on a narrow set musculoskeletal and neurological diseases and injuries (i.e., did not account for
infectious or most neonatal conditions), we rather observed a linear instead of logarithmic growth
in YLD Rates. Global development and advances in disease treatment and prevention in LMICs
(e.g., targeting communicable, neonatal, and maternal conditions) result in higher life expectancy in
these countries—hence higher likelihood of people experiencing, surviving, and living longer with
chronic conditions or long-term disabilities, including those arising from age-related musculoskeletal
or neurological conditions. [1–3] This epidemiological transition in LMICs has been observed for
longer in high-income countries, and result in a trend for increasing YLD Rates, especially from
musculoskeletal and neurogical conditions, which are not likely addressed by vertical, disease-focused
approaches. Even infectious or neonatal conditions might not have been addressed in their sequalae
(i.e., toward reducing or mitigating their disability through rehabilitation) as much as in its prevalence.
For instance, while children with complex health conditions and people with HIV/AIDs increasingly
survive in LMICs, the associated disabilities and rehabilitation needs remain often unmet [84,86,89–92].
In this scenario, granting access to needed rehabilitation (e.g., through horizontal, sustainable health
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systems’ strengthening [24]), especially in LMICs, is of utmost importance [24,85,87], and justified by
the current YLDs data.
In addition to resource increases, innovative solutions might be further developed toward
increasing access to timely and high quality rehabilitation services for locations with suboptimal
or unevenly distributed rehabilitation resources. Potential solutions are needed for rehabilitation
delivered at home and in the community, offering the potential that tele-rehabilitation may help fill the
gap [43,86,93–98]. Task-shifting to healthcare assistants or team-based community care, especially in
LMICs, is another potential option to meet global health needs in LMICs warranting future research
and development [99].
Only in high-income countries did Age-standardized YLDs diminish over time, whereas in
LMICs they did not significantly change or have significantly increased since 1990. This pattern
was consistent for both of our analyses: that on the overall physical rehabilitation needs, and that
focused on a narrow set of neurological and musculoskeletal conditions. We hypothesize that the wide
implementation of public and private physical rehabilitation services in high-income countries, but to
a far lesser extent in LMICs, has contributed to these findings. Historically, LMICs’ health systems
and global health activities have been focused in reducing preventable mortality, while the global
burden of non-fatal health losses has been lagging in terms of global health priority, resources, and
gains [1,5,6,100]. Fortunately, there is now a global awareness about the need to avert preventable YLDs
through appropriate healthcare services, including rehabilitation [5,6,24,101]. Similarly, global health
policies are, now, more inclusive of people with disabilities and their rehabilitation needs [87,102,103].
Finally, the evidence of cost-effectiveness of rehabilitation is escalating [44,104]. In this context, our
finding that Age-standardized YLDs was significantly reduced in high-income countries, but not in
LMICs—and at times significantly increased in LMICs, can be yet another indicator of the need to
scale up rehabilitation services in LMIC’s health systems [24]. Cardiac rehabilitation programs might
be a good example, as they have been proven cost-effective [44], are generally standard practice in
high-income countries, yet barely existent in many LMICs [105–107], even though service delivery
models suitable to the LMICs have been developed [108].
Finally, we found the percentage of YLDs likely benefiting from physical rehabilitation increased
significantly and linearly across analyzed locations. Furthermore, we observed a trend toward
convergence, as the high-income countries had the highest value in 2017, but the growth in LMICs
has been significantly higher since 1990. However, even in high-income countries, a significant
growth has been persisting over time in the overall physical rehabilitation needs, indicating that the
ceiling has not been reached yet in the percentage of YLDs Benefiting from Physical Rehabilitation.
That ceiling, however, was found in the analysis narrowly focused on key musculoskeletal and
neurological conditions. Therefore, in high-income countries, the areas of physical rehabilitation
practice emerging in the more recent decades (e.g., focused on neoplasms or cardiothoracic conditions)
have been, altogether, key for the continued growth in the percentage of YLDs Benefiting from Physical
Rehabilitation. The higher the percent value, the higher the expected impact of physical rehabilitation,
i.e., in terms of being able to reduce a higher share of the global burden of non-fatal health conditions.
Limitations
The paper’s limitations are the following: First, the YLD measure is, at best, a proxy indicator
of need for physical rehabilitation. For instance, functional data at the population level, e.g., from
the Model Disability Survey, and/or other disability statistics, whenever available, might be used
in alternative or complement to provide a more comprehensive picture of populations’ physical
rehabilitation needs [85,109–111]. This limitation notwithstanding, the GBD is the most comprehensive
source of global epidemiological data to date, and GBD data are widely used to analyze of the needs
for, or benefits from, specific types of healthcare [112–115].
Second, there is no global standard of conditions that potentially benefit from physical
rehabilitation which we could use for the selection of specific health conditions to include in our main
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analyses. To inform that selection, we relied on previous research on physical rehabilitation, a working
definition of physical rehabilitation, and tailored searches on PubMed. Nonetheless, tailored searches
conducted on PubMed, to identify and help select of health conditions likely benefiting from physical
rehabilitation, do not equate to a systematic review itself. For conditions which were particularly
uncertain with regards to potential benefits from physical rehabilitation, we employed explicit, a priori
evidence-informed reasoning about the potential trade-offs for over- vs. under-estimation of physical
rehabilitation needs.
Third, while a separate analysis for a subgroup of health conditions historically associated with
physical rehabilitation need is present, it does not equate to minimum requirements in terms of
a physical rehabilitation need.
Fourth, once we partly relied on published evidence to ground selection decisions and our
trade-off reasoning, any under-research on the rehabilitation of conditions less common in high-income
countries (e.g., tuberculosis, malaria) might have biased that reasoning. It is unknown whether the
such putative under-research contributes under-estimate the magnitude of physical rehabilitation
needs, especially in lower income countries.
Fifth, we used inferential statistics with YLD estimates, rather than direct data collection with
metrics to quantify the nature and degree of physical disability. Moreover, the uncertainty intervals of
the underlying YLD estimates could not be computed for our ‘combined’ values (i.e., the sum of YLDs
from all health conditions likely benefeting from physical rehabilitation), although they exist in the
public domain for each included condition in isolation [6].
Sixth, the quantity and accuracy of the data used to compute the GBD estimates is typically lower
in lower income countries, which can include a less accurate detection or registry of data for many
health conditions, especially non-communicable diseases or injuries. That can partly justify why the
LMICs have much lower values for example in the Age-Standardized YLD Rates, across the time-series,
when compared to high-income countries. Therefore, it is possible that the true magnitude of physical
rehabilitation needs in LMICs remain partly obscure in these results. In addition, the quantity and
accuracy of the underlying data in 2017 is likely superior to what it was back in 1990. This means
a lower precision for the GBD estimates for the earlier years. However, lower preciseness does not
imply systematic error (i.e., bias) toward over- or under-estimation of YLDs for the earlier times.
To reduce potential bias, at each new cycle, the GBD study uses the more complete and updated data,
measurement and classification systems, and estimation methods to re-calculate the entire time-series,
not just the estimates for the more recent years [6].
Seventh, the presence of auto-correlation in the time series was not ruled out, i.e., we did not
assess whether error terms were significantly correlated over time. Nonetheless, many of the simple
linear regression models had nearly perfect fits with the underlying time series data, meaning that the
magnitude of each of those errors was negligible. In addition, we used only simple linear regression
analyses which did not account for what had changed over time apart from population growth
and ageing. The latter ones here were inherently accounted for when we performed analyses using
“Age-standardized YLD Rates” instead of simple YLD counts.
Finally, we focused on evolving trends for overall needs for physical rehabilitation and then in
a narrow, conservative subgroup of conditions benefeting from physical rehabilitation, and did not
perform sub-group analyses across specific groups of conditions (e.g., musculoskeletal, neurological,
cardiac, etc.) as these have been performed by other groups that have used GBD data.
5. Conclusions
This systematic secondary analysis of the GBD 2017 provides global data on current physical
rehabilitation needs, and on how those needs evolved since 1990, including across countries of varying
income level.
Physical rehabilitation needs have been growing significantly over time across locations, not only
in absolute terms, but also per-capita and in percentage of the total amount of total YLDs. This means
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that not only has physical rehabilitation been growing, but also that physical rehabilitation is now
capable of averting a higher portion of the global burden of disability. The highest absolute growth of
physical rehabilitation needs was observed in countries of lower income level, which typically have
deprived rehabilitation infrastructure. Finally, only in high-income countries did a significant reduction
in age-standardized needs per capita occur, which can be related to the wider implementation of
physical rehabilitation services in these countries.
The use of the comprehensive, up-to-date GBD estimates for the needs-side of the rehabilitation
resources-planning equation, albeit imperfect, is a readily available means to help health planners to
meet the physical rehabilitation needs of the global population. These needs were found to be high
and increasing, including per-capita, across countries of varying income level.
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Appendix A
A On the side of Over-Estimation, we ended up Including the sequelae (i.e., YLDs) from:
• All Cardiovascular (“causes”):
◦ Currently, the quantity, quality and strength of the evidence base for cardiac rehabilitation
varies across treated conditions [36–43], but strong evidence supports that cardiac
rehabilitation approaches are overall cost-effective [44].
• All Chronic Respiratory Diseases (“causes”):
◦ Although the evidence is more established for pulmonary rehabilitation applied to patients
with chronic obstructive pulmonary disease [45,46], evidence of the benefit of pulmonary
rehabilitation begins to emerge for other conditions as well [47,48].
• All Neonatal Conditions (“causes”).
◦ We include all neonatal conditions, including “Hemolytic diseases and other neonatal
jaundice”. For instance, although frequently benign, neonatal jaundice can become severe
and lead to encephalopathy and neurodevelopment impairments [49]. Hence, sequalae
(i.e., YLDs) from this condition would be amenable to physical rehabilitation. Overall,
sequalae from neonatal conditions would likely lead to some form of physical, neurological
or motor impairments or delays that are amenable to physical rehabilitation, although we
acknowledge that they might not be present in all cases and therefore the possibility of some
error on side of overestimation.
• Alzheimer’s Disease and other Dementias.
◦ A wide scope of mental, cognitive as well as physical impairments and rehabilitation needs
are associated with these conditions, which progress to affect the activities of daily living
(ADLs) and mobility, inclusively from deconditioning. Evidence points out that exercise
programs may at least improve the ability to perform ADLs in people with dementia, as in
the following examples:
Therapeutic interventions that include aerobic and strengthening exercises may help improve
independence in ADLs and improve physical performance in people with Alzheimer’s
Disease [50]. Strong evidence also supports the benefits of occupation-based interventions
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and physical exercise for adults with Alzheimer’s Disease and related major neurocognitive
disorders [51]. Some evidence hints that physical activity can even improve or slow down
decreases in cognitive functioning [52,53]. Even though a Cochrane review in 2015 found no
evidence of benefit from exercise on cognition, neuropsychiatric symptoms, or depression,
benefits in ADLs were found [54]. Finally, another systematic review hints that preliminary
support exists for the effectiveness of physical therapy and exercise interventions in patients
with Huntington’s Disease [55].
Overall, the inclusion of these conditions can lead to an over-estimation of YLDs amenable
to physical rehabilitation as the severity and respective disability weights of these conditions
also account for cognitive and mental health needs.
• Autism Spectrum Disorder:
◦ Even though psychosocial dysfunction might be dominant, sensory-processing and
motor impairments are prevalent and might be addressed by physical rehabilitation
approaches [29–35], yet these impairments are not always present and psychosocial
disfunction is often dominant. This means that YLDs from this condition are also
germane to other forms of rehabilitative or habilitative interventions—therefore, the possible
over-estimation of physical rehabilitation needs from YLDs that came from this condition.
B On the side of Under-Estimation, we ended up Excluding the sequelae (i.e., YLDs) from:
• Tuberculosis:
◦ Although physical impairments might come as sequalae of this condition, we only found a
study protocol for a scoping review on the subject [56], whose findings may inform a further
systematic review to explore the effectiveness of rehabilitation strategies used to address
physical impairments and activity limitations in people with this infection. At today’s level
of synthesized evidence, we did not include this condition.
• Malaria:
◦ We did not find a strong, recent body of evidence systematically reviewed regarding
the effect of physical or even cognitive rehabilitation interventions, even though cognitive
impairments are prevalent sequelae in a sub-set of people with malaria and rehabilitative
solutions have been proposed, including physical therapy and speech therapy [57]. Malaria
is pointed out as one of the possible causes of the disproportionate, high prevalence of
cerebral palsy in low-income countries [58]. While that consequence would be amenable
to physical rehabilitation, we did not find a systematic study or review on that linkage,
inclusively detailing the proportion of cases with sequalae from malaria that lead to cerebral
palsy. Therefore, we did not include YLDs from this condition.
• Other Neglected Tropical Diseases (apart from Leprosy and Zika Virus):
◦ For Zika Virus and Leprosy we have found reviews or overviews on the likely benefit
of physical rehabilitation approaches [59–61]. All other conditions in this category were
not included, given the lack of identified research or reviews of research focused on the
rehabilitation of those conditions.
• Epilepsy:
◦ While sequalae from Epilepsy may benefit from cognitive rehabilitation [62], the topic is
under-researched [63] and cognitive rehabilitation only partly relates to physical rehabilitation.
• Migraine:
◦ There is a body of evidence supporting the benefits of physical therapy for migraine
and other headaches, but the methodological shortcomings reduce the confidence in the
results [64]. Besides, physical therapy in migraine is more controversial than in tension-type
headaches (TTH), since migraine pathogenesis involves activation of sub-cortical structures
and the trigemino-vascular system, whereas pathogenesis of TTH is more associated with
musculoskeletal disorders, e.g., muscle pain [65]. Finally, we have found systematically
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reviewed information supporting specific types of physical therapy interventions for
TTH [66]. Hence, we have included TTH, but not migraine, even though it cannot be
ruled out the effectiveness of physical therapy across headache conditions.
• Attention Deficit Hyperactivity Disorder:
◦ Even though occupational therapy interventions can have positive impacts in children’s
participation and executive functions [67], the cognitive-functional scope of the intervention
only partly relates with physical rehabilitation, and we did not find any systematic reviews
supporting the benefit of interventions within the realm of physical rehabilitation for
this condition.
• Diabetes
◦ Even at the 5th level of the GBD hierarchy, the one with higher detail, we do not have the
data for amputation as a consequence of diabetes, for example in contrast with kidney
diseases. In these circumstances, we altogether exclude YLDs from diabetes to avoid
many false positives in terms of physical rehabilitation need, notably from kidney and
eye impairments.
• All mental health conditions and substance abuse.
◦ Even considering that for example physical activity/exercise have benefits for
depression [68,69], the type of exercise does not necessarily equate to physical rehabilitation
and the overall rehabilitative approach can be rather framed in the context of mental
health/psychosocial rehabilitation.
• Maternal, Urological, or Gynecological or conditions.
◦ Even though there is a body of literature pointing out that physical therapy can be useful
on strengthening the pelvic floor muscles and reducing related incontinence (versus no
treatments) or even reduce vestibulodynia [70,71], the underlying evidence base, for example
on the chronic pelvic pain and incontinence (when added to another active treatment)
still is considered insufficient [72–75]. Finally, it was complex to depict which are the
GBD “causes” resulting in those symptoms, and there are no GBD “impairments” for
example about incontinence. So, we altogether have excluded the maternal, urological or
gynecological diseases, even though some might generate YLDs eventually amenable to
physical rehabilitation.
• Nutritional deficiencies:
◦ Sequalae from nutritional deficiencies can be many and varied. Therefore, some of
the YLDs can be amenable to physical rehabilitation while many others not. For instance,
even though Iodine Deficiency can lead to fatigue and that can be possibly addressed
by physical rehabilitation, it often leads to more significant sequalae in terms of mental
development [76,77]. We avoided the inclusion of conditions from which we can expect a
high rate of YLDs not amenable to physical rehabilitation.
• Unspecific conditions such as “Other Non-communicable diseases”, “Effect of different
environmental factors” and “Complications following therapeutic procedures”
◦ In some cases, these unspecific conditions might lead to physical rehabilitation needs
(e.g., hemorrhage after neurosurgery that leads to spinal cord damage) or not (e.g., wound
infection after surgery). In a conservative approach, we opt not to include too many
false positives.
• Physical rehabilitation needs from deconditioning in turn arising from non-specific causes
(e.g., hospital-associated deconditioning), or even physical rehabilitation needs arising from
senescence, i.e., with no need for an underlying disease or injury.
◦ This type of impairments could not be determined using the GBD as reference, even
though they might count as physical rehabilitation needs [78,79].
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